Related Experiment Video
Updated: Aug 9, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac sarcoidosis presenting with cardiogenic shock successfully recovered by Impella and corticosteroid pulse
Miho Hashimura1, Yuki Ikeda1, Toshimi Koitabashi1
1Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-Ku, Sagamihara, Kanagawa 252-0374, Japan.
Insights
Cardiac sarcoidosis (CS) can cause severe heart problems. This case shows that high-dose steroids combined with Impella heart support can effectively treat CS hemodynamic collapse, aiding recovery.
Area of Science:
- Cardiology
- Immunology
- Critical Care Medicine
Background:
- Cardiac sarcoidosis (CS) is an inflammatory condition that can lead to significant cardiac dysfunction and arrhythmias.
- Hemodynamic instability is a critical complication of advanced CS.
- Early diagnosis and intervention are crucial for managing CS.
Observation:
- A 70-year-old woman with CS presented with syncope due to complete atrioventricular block and ventricular tachycardia.
- She experienced cardiopulmonary arrest from ventricular fibrillation, requiring resuscitation.
- Sustained hypotension and impaired left ventricular function necessitated Impella cardiac power (CP) support.
Findings:
- High-dose intravenous corticosteroid therapy was initiated concurrently with Impella CP.
- The patient demonstrated dramatic improvement in atrioventricular conduction and left ventricular function.
- Impella CP was successfully weaned after 4 days, and the patient was discharged on maintenance steroids.
Implications:
- This case highlights the potential efficacy of combining high-dose corticosteroids with mechanical circulatory support (Impella CP) in managing fulminant CS with hemodynamic collapse.
- Impella CP can serve as a crucial bridge, allowing time for steroid therapy to exert its beneficial effects in severe CS.
- Aggressive immunosuppressive and hemodynamic support strategies may improve outcomes in patients with life-threatening cardiac sarcoidosis.
Background:
Cardiac sarcoidosis (CS) occasionally disrupts circulatory haemodynamics due to arrhythmia or cardiac dysfunction.
Case Summary:
A 70-year-old woman was diagnosed with CS, then was admitted for syncope because of complete atrioventricular block and frequently non-sustained ventricular tachycardia. Although a temporary pacemaker and intravenous amiodarone were introduced, she subsequently went into cardiopulmonary arrest by ventricular fibrillation. After the return of spontaneous circulation, Impella cardiac power (CP) was introduced because of sustained hypotension and severely impaired left ventricular contraction. High-dose intravenous corticosteroid therapy was simultaneously introduced. Her atrioventricular conduction and left ventricular contraction drastically improved. Impella CP was successfully removed after 4 days of support. She was eventually administered steroid maintenance therapy and discharged.
Discussion:
We report a case of CS with fulminant haemodynamic collapse treated with high-dose intravenous corticosteroid therapy under Impella assistance for acute haemodynamic support. Although CS has been known as an inflammatory disease with progressive cardiac dysfunction and rapid deterioration due to fatal arrhythmias, it can be improved with steroid therapy. It was suggested that strong haemodynamic support by Impella could be a bridge to manifest the effects after introducing steroid therapy to patients with CS.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pericarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy

